trustme.bro/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim
T-cell receptors have been engineered on viral capsids to target cancer cells.
the verdict
OVERSTATED
true in a weaker form than the claim states
confidence 0/100

Recent advancements in immunotherapy demonstrate that viral capsids and virus-like particles can be engineered to deliver receptor-based constructs like CARs to target cancer cells.

what the evidence does support

Viral capsids and virus-like particles can be engineered to deliver receptor-based constructs to target cancer cells.

Evidence for · 2
Optimizing In Vivo CAR T-cell Engineering for Cancer Immunotherapy.
2026 · cited by 1
Discusses viral vectors and viral-like particles engineered for in vivo CAR T-cell delivery and targeting.
See more details
More for · 1
Transient T cell therapies.
2026 · cited by 0
Mentions engineered virus-like particles used for delivering transient CAR therapies in situ.
The paper trail · every fact has a biography
first checked02 Aug 2026
judged → OVERSTATED · 002 Aug 2026
This receipt carries no identity, shared or not. Sharing publishes your connection to it, not your data.
Check your own claim
Challenge the receipt
trust me, bro: win the argument, pass the class, survive peer review.
This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work · Dispute this receipt